S M Lichtman

Summary

Affiliation: North Shore University Hospital
Country: USA

Publications

  1. ncbi Aggressive lymphoma in the elderly
    S M Lichtman
    Department of Medicine, North Shore University Hospital New York University School of Medicine, Manhasset 11030, USA
    Crit Rev Oncol Hematol 33:119-28. 2000
  2. ncbi Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital, Manhasset, New York, USA
    Leuk Lymphoma 28:423-7. 1998
  3. ncbi Pharmacology of antineoplastic agents in older cancer patients
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital New York University, School of Medicine, Manhasset, New York, USA
    Oncology (Williston Park) 14:1743-55; discussion 1755, passim. 2000
  4. ncbi Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies
    S M Lichtman
    Divisions of Medical Oncology, Department of Medicine, North Shore University Hospital, Manhasset, New York 11030, USA
    Am J Hematol 61:262-4. 1999
  5. ncbi Chemotherapy in the elderly: pharmacologic considerations
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital New York University School of Medicine, Manhasset 11030, USA
    Cancer Control 7:548-56. 2000
  6. ncbi Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B
    S M Lichtman
    Don Monti Division of Oncology, North Shore University Hospital NYU School of Medicine, Manhasset, New York 11030, USA
    Ann Oncol 11:1141-6. 2000
  7. ncbi Integration of geriatrics in oncology training--the relationship between the academic center and the community
    S M Lichtman
    Department of Medicine, North Shore University Hospital, New York University School of Medicine, Manhasset 11030, USA
    Crit Rev Oncol Hematol 33:57-9. 2000
  8. ncbi Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial
    S M Lichtman
    Don Monti Division of Oncology, Department of Medicine, North Shore University, Hospital Cornell University Medical College, Manhasset, New York 11030
    Am J Clin Oncol 14:317-21. 1991
  9. ncbi High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150
    S M Lichtman
    Don Monti Division of Oncology, North Shore University Hospital, New York University School of Medicine, Manhasset, USA
    Leuk Lymphoma 42:1255-64. 2001
  10. ncbi Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840
    S M Lichtman
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York 11725, USA
    Ann Oncol 23:632-8. 2012

Detail Information

Publications15

  1. ncbi Aggressive lymphoma in the elderly
    S M Lichtman
    Department of Medicine, North Shore University Hospital New York University School of Medicine, Manhasset 11030, USA
    Crit Rev Oncol Hematol 33:119-28. 2000
    ..Future research should include defining the role of comorbidity, measurement of organ dysfunction and assessment of performance status with geriatric functional scales. New drug treatments should also be explored...
  2. ncbi Development of essential thrombocythemia in a patient treated with interferon alfa and pentostatin for hairy cell leukemia
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital, Manhasset, New York, USA
    Leuk Lymphoma 28:423-7. 1998
    ..These malignancies may represent either a new clonal disorder or a complication of drug treatment. This is the first report of a chronic myeloproliferative disorder following successful treatment of hairy cell leukemia...
  3. ncbi Pharmacology of antineoplastic agents in older cancer patients
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital New York University, School of Medicine, Manhasset, New York, USA
    Oncology (Williston Park) 14:1743-55; discussion 1755, passim. 2000
    ..e., renal and hepatic) dysfunction. These adjustments will be discussed for specific drugs. Complementary and alternative therapies will also be presented...
  4. ncbi Secondary hemochromatosis as a long-term complication of the treatment of hematologic malignancies
    S M Lichtman
    Divisions of Medical Oncology, Department of Medicine, North Shore University Hospital, Manhasset, New York 11030, USA
    Am J Hematol 61:262-4. 1999
    ..This may prevent the development of clinically significant chronic liver disease and possibly malignancy...
  5. ncbi Chemotherapy in the elderly: pharmacologic considerations
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital New York University School of Medicine, Manhasset 11030, USA
    Cancer Control 7:548-56. 2000
    ..A better understanding of the effects of chemotherapeutic agents on older patients with cancer will help to determine the appropriate use of chemotherapy for this age group...
  6. ncbi Phase II study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B
    S M Lichtman
    Don Monti Division of Oncology, North Shore University Hospital NYU School of Medicine, Manhasset, New York 11030, USA
    Ann Oncol 11:1141-6. 2000
    ..Patients with resistant diffuse aggressive non-Hodgkin's lymphoma (DA-NHL) have a poor prognosis. Studies have suggested infusional therapy may be beneficial...
  7. ncbi Integration of geriatrics in oncology training--the relationship between the academic center and the community
    S M Lichtman
    Department of Medicine, North Shore University Hospital, New York University School of Medicine, Manhasset 11030, USA
    Crit Rev Oncol Hematol 33:57-9. 2000
    ..Integration of geriatric and medical oncology training would be an important step in this process. This paper discusses various aspects of a combined educational proposal...
  8. ncbi Adjuvant therapy of stage II breast cancer treated with CMFVP, radiation therapy and VATH following lumpectomy. A pilot trial
    S M Lichtman
    Don Monti Division of Oncology, Department of Medicine, North Shore University, Hospital Cornell University Medical College, Manhasset, New York 11030
    Am J Clin Oncol 14:317-21. 1991
    ..The doses of VATH were not compromised by the prior therapy. The regimen was found to be tolerable and is a reasonable approach in the adjuvant treatment of this particular patient population...
  9. ncbi High dose cyclophosphamide plus recombinant human granulocyte-colony stimulating factor (rhG-CSF) in the treatment of follicular, low grade non-Hodgkin's lymphoma: CALGB 9150
    S M Lichtman
    Don Monti Division of Oncology, North Shore University Hospital, New York University School of Medicine, Manhasset, USA
    Leuk Lymphoma 42:1255-64. 2001
    ..5 g/m2 every two weeks with rhG-CSF support can be administered to selected younger patients with advanced follicular lymphoma with morphologic involvement of the bone marrow with acceptable non-hematologic toxicity...
  10. ncbi Paclitaxel efficacy and toxicity in older women with metastatic breast cancer: combined analysis of CALGB 9342 and 9840
    S M Lichtman
    Department of Medicine, Memorial Sloan Kettering Cancer Center, New York 11725, USA
    Ann Oncol 23:632-8. 2012
    ..Two Cancer and Leukemia Group B (CALGB) studies were utilized to determine the efficacy and tolerability of paclitaxel (Taxol) in older patients with metastatic breast cancer...
  11. ncbi A phase I study of sequential vinorelbine followed by paclitaxel
    D R Budman
    Don Monti Division of Oncology, Department of Medicine, North Shore University Hospital, New York University School of Medicine, Manhasset, USA
    Ann Oncol 10:861-3. 1999
    ..A phase I dose escalation trial of vinorelbine daily x 3 with paclitaxel on day 3 repeated every 28 days in metastatic breast cancer patients was completed...
  12. ncbi Preliminary studies of a novel oral fluoropyrimidine carbamate: capecitabine
    D R Budman
    Department of Medicine, North Shore University Hospital, New York University Medical College, Manhasset 11030, USA
    J Clin Oncol 16:1795-802. 1998
    ....
  13. ncbi Treatment of aggressive non-Hodgkin's lymphoma in elderly patients with thiotepa, Novantrone (mitoxantrone), vincristine, prednisone (TNOP)
    S M Lichtman
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital--New York University School of Medicine, Manhasset, New York 11030, USA
    Am J Clin Oncol 24:360-2. 2001
    ..The median survival was 26 months. Hematologic and nonhematologic toxicity was tolerable. We believe that TNOP is an excellent therapeutic option in this group of elderly patients, particularly in the palliative setting...
  14. ncbi Clinical research in the older cancer patient
    H B Muss
    Department of Medicine, Vermont Cancer Center, University of Vermont College of Medicine, Burlington, USA
    Hematol Oncol Clin North Am 14:283-91. 2000
    ..Oncologists and geriatricians must work together to guarantee that appropriate funding is made available for cancer research in the elderly population...
  15. ncbi Recombinant human erythropoietin use in hemolytic anemia due to prosthetic heart valves: a promising treatment
    S Hirawat
    Don Monti Division of Medical Oncology, Department of Medicine, North Shore University Hospital-New York University School of Medicine, Manhasset, New York 11030, USA
    Am J Hematol 66:224-6. 2001
    ..Two patients are reported with hemolytic anemia due to red blood cell fragmentation in association with prosthetic heart vales. They were treated with erythropoietin which eliminated the need for packed red blood cell transfusion...